Aurobindo Pharma Limited has submitted a regulatory disclosure to the National Stock Exchange of India Limited and BSE Limited regarding its participation in an investor meeting.
The company officials will participate in the BofA 2026 India Conference, which is scheduled for June 2, 2026, from 9:00 AM to 6:00 PM IST. The meetings will be conducted in-person as group meetings at the location in Mumbai.
The company specifically stated that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions. The schedule of the meeting is subject to change due to exigencies on the part of either the Investor or the Company.